The Tunisian government has officially approved a 130-dinar financial allowance for individuals suffering from celiac disease, also known as coeliac disease or 'Al-Batn' in Arabic. However, despite being enshrined in law and published in the Official Gazette, the disbursement of this allowance has been delayed. Dr. Moungi Ben Hariz, head of the Tunisian Association for Celiac Disease Patients, highlighted that several months have passed since the allowance's approval, yet it remains unfunded.
According to Dr. Ben Hariz, the delay is attributed to cumbersome administrative procedures. Patients are required to submit a medical certificate issued by a doctor within the public healthcare system and have their files reviewed by a special committee. These requirements have slowed down the disbursement process and placed an additional burden on patients, particularly those with limited financial resources.
The Tunisian Association for Celiac Disease Patients has urged the relevant authorities to expedite the allowance's disbursement and simplify administrative procedures. Patients with celiac disease face increasing financial difficulties due to the rising costs of gluten-free food products, which are essential to their daily lives. The association also called for a review of the allowance's value, seeking an increase to alleviate the financial burden on patients and their families.
Celiac disease is a chronic autoimmune disorder that requires a strict gluten-free diet. In Tunisia, the cost of gluten-free products is significantly higher than their gluten-containing counterparts, placing a substantial financial strain on patients. The delayed allowance has exacerbated the challenges faced by these individuals, who often struggle to afford the necessary food products.
Dr. Ben Hariz emphasized that the association is working to raise awareness about celiac disease and advocate for the rights of patients. He stressed the importance of collaboration between healthcare providers, policymakers, and patient advocacy groups to address the challenges faced by individuals with celiac disease.
The Tunisian government has taken steps to improve healthcare services and support for patients with chronic conditions. However, the delayed disbursement of the celiac disease allowance has highlighted the need for more efficient administrative processes and increased financial support for vulnerable populations.
The Tunisian Association for Celiac Disease Patients continues to push for the timely disbursement of the allowance and improved support for its members. As the situation unfolds, patients and advocacy groups remain hopeful that the government will address their concerns and provide the necessary assistance to alleviate the financial burden of living with celiac disease.
Key points
- The Tunisian government's 130-dinar allowance for celiac disease patients has been delayed due to administrative hurdles.
- Patients with celiac disease face significant financial challenges due to the high cost of gluten-free food products.
- The Tunisian Association for Celiac Disease Patients is advocating for the expedited disbursement of the allowance and increased financial support for its members.
